<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="hesr14200" xml:lang="en" article-type="methods-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Health Serv Res</journal-id><journal-id journal-id-type="iso-abbrev">Health Serv Res</journal-id><journal-id journal-id-type="pmc-domain-id">235</journal-id><journal-id journal-id-type="pmc-domain">hsresearch</journal-id><journal-id journal-id-type="publisher-id">HESR</journal-id><journal-title-group><journal-title>Health Services Research</journal-title></journal-title-group><issn pub-type="ppub">0017-9124</issn><issn pub-type="epub">1475-6773</issn><publisher><publisher-name>Health Research &amp; Educational Trust</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10480090</article-id><article-id pub-id-type="pmcid-ver">PMC10480090.1</article-id><article-id pub-id-type="pmcaid">10480090</article-id><article-id pub-id-type="pmcaiid">10480090</article-id><article-id pub-id-type="pmid">37408299</article-id><article-id pub-id-type="doi">10.1111/1475-6773.14200</article-id><article-id pub-id-type="publisher-id">HESR14200</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Methods Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Methods Corner</subject></subj-group></article-categories><title-group><article-title>Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources&#8212;Rhode Island, Massachusetts, and New York City, 2013&#8211;2019</article-title><alt-title alt-title-type="left-running-head">Chatterjee et al.</alt-title></title-group><contrib-group><contrib id="hesr14200-cr-0001" contrib-type="author" corresp="yes"><name name-style="western"><surname>Chatterjee</surname><given-names initials="A">Avik</given-names></name><degrees>MD, MPH</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8437-6774</contrib-id><xref rid="hesr14200-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>avik.chatterjee@bmc.org</email></address></contrib><contrib id="hesr14200-cr-0002" contrib-type="author"><name name-style="western"><surname>Yan</surname><given-names initials="S">Shapei</given-names></name><degrees>MPH</degrees><xref rid="hesr14200-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hesr14200-cr-0003" contrib-type="author"><name name-style="western"><surname>Lambert</surname><given-names initials="A">Audrey</given-names></name><degrees>MPH</degrees><xref rid="hesr14200-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hesr14200-cr-0004" contrib-type="author"><name name-style="western"><surname>Morgan</surname><given-names initials="JR">Jake R.</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1559-3983</contrib-id><xref rid="hesr14200-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hesr14200-cr-0005" contrib-type="author"><name name-style="western"><surname>Green</surname><given-names initials="TC">Traci C.</given-names></name><degrees>PhD, MSc</degrees><xref rid="hesr14200-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="hesr14200-cr-0006" contrib-type="author"><name name-style="western"><surname>Jeng</surname><given-names initials="PJ">Philip J.</given-names></name><degrees>MS</degrees><xref rid="hesr14200-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="hesr14200-cr-0007" contrib-type="author"><name name-style="western"><surname>Jalali</surname><given-names initials="A">Ali</given-names></name><degrees>PhD</degrees><xref rid="hesr14200-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="hesr14200-cr-0008" contrib-type="author"><name name-style="western"><surname>Xuan</surname><given-names initials="Z">Ziming</given-names></name><degrees>ScD, SM, MA</degrees><xref rid="hesr14200-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="hesr14200-cr-0009" contrib-type="author"><name name-style="western"><surname>Krieger</surname><given-names initials="M">Maxwell</given-names></name><degrees>BS</degrees><xref rid="hesr14200-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="hesr14200-cr-0010" contrib-type="author"><name name-style="western"><surname>Marshall</surname><given-names initials="BDL">Brandon D. L.</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0134-7052</contrib-id><xref rid="hesr14200-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="hesr14200-cr-0011" contrib-type="author"><name name-style="western"><surname>Walley</surname><given-names initials="AY">Alexander Y.</given-names></name><degrees>MD, MSc</degrees><xref rid="hesr14200-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="hesr14200-cr-0012" contrib-type="author"><name name-style="western"><surname>Murphy</surname><given-names initials="SM">Sean M.</given-names></name><degrees>PhD</degrees><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-9104-0670</contrib-id><xref rid="hesr14200-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib></contrib-group><aff id="hesr14200-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine</named-content>
<institution>Boston Medical Center/Boston University School of Medicine</institution>
<city>Boston</city>
<named-content content-type="country-part">Massachusetts</named-content>
<country country="US">USA</country>
</aff><aff id="hesr14200-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Boston University School of Public Health</institution>
<city>Boston</city>
<named-content content-type="country-part">Massachusetts</named-content>
<country country="US">USA</country>
</aff><aff id="hesr14200-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">The Heller School for Social Policy and Management</named-content>
<institution>Brandeis University</institution>
<city>Waltham</city>
<named-content content-type="country-part">Massachusetts</named-content>
<country country="US">USA</country>
</aff><aff id="hesr14200-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Population Health Sciences</named-content>
<institution>Weill Cornell Medical College</institution>
<city>New York City</city>
<named-content content-type="country-part">New York</named-content>
<country country="US">USA</country>
</aff><aff id="hesr14200-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Epidemiology</named-content>
<institution>Brown University School of Public Health</institution>
<city>Providence</city>
<named-content content-type="country-part">Rhode Island</named-content>
<country country="US">USA</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Avik Chatterjee, Grayken Center for Addiction, Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center/Boston University School of Medicine, 72 E Newton St, Boston, MA 02118, USA.<break/>
Email: <email>avik.chatterjee@bmc.org</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>7</month><year>2023</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2023</year></pub-date><volume>58</volume><issue seq="180">5</issue><issue-id pub-id-type="pmc-issue-id">444766</issue-id><issue-id pub-id-type="doi">10.1111/hesr.v58.5</issue-id><fpage>1141</fpage><lpage>1150</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-01 00:25:29.690"><day>01</day><month>10</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 Health Research and Educational Trust.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="HESR-58-1141.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:HESR-58-1141.pdf"/><abstract><title>Abstract</title><sec id="hesr14200-sec-0001"><title>Objective</title><p>Accurate naloxone distribution data are critical for planning and prevention purposes, yet sources of naloxone dispensing data vary by location, and completeness of local datasets is unknown. We sought to compare available datasets in Massachusetts, Rhode Island, and New York City (NYC) to a commercially available pharmacy national claims dataset (Symphony Health Solutions).</p></sec><sec id="hesr14200-sec-0002"><title>Data Sources and Study Setting</title><p>We utilized retail pharmacy naloxone dispensing data from NYC (2018&#8211;2019), Rhode Island (2013&#8211;2019), and Massachusetts (2014&#8211;2018), and pharmaceutical claims data from Symphony Health Solutions (2013&#8211;2019).</p></sec><sec id="hesr14200-sec-0003"><title>Study Design</title><p>We conducted a descriptive, retrospective, and secondary analysis comparing naloxone dispensing events (NDEs) captured via Symphony to NDEs captured by local datasets from the three jurisdictions between 2013 and 2019, when data were available from both sources, using descriptive statistics, regressions, and heat maps.</p></sec><sec id="hesr14200-sec-0004"><title>Data Collection/Extraction Methods</title><p>We defined an NDE as a dispensing event documented by the pharmacy and assumed that each dispensing event represented one naloxone kit (i.e., two doses). We extracted NDEs from local datasets and the Symphony claims dataset. The unit of analysis was the ZIP Code annual quarter.</p></sec><sec id="hesr14200-sec-0005"><title>Principal Findings</title><p>NDEs captured by Symphony exceeded those in local datasets for each time period and location, except in RI following legislation requiring NDEs to be reported to the PDMP. In regression analysis, absolute differences in NDEs between datasets increased substantially over time, except in RI before the PDMP. Heat maps of NDEs by ZIP code quarter showed important variations reflecting where pharmacies may not be reporting NDEs to Symphony or local datasets.</p></sec><sec id="hesr14200-sec-0006"><title>Conclusions</title><p>Policymakers must be able to monitor the quantity and location of NDEs in order to combat the opioid crisis. In regions where NDEs are not required to be reported to PDMPs, proprietary pharmaceutical claims datasets may be useful alternatives, with a need for local expertise to assess dataset&#8208;specific variability.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="hesr14200-kwd-0001">drug policy</kwd><kwd id="hesr14200-kwd-0002">harm reduction</kwd><kwd id="hesr14200-kwd-0003">naloxone</kwd><kwd id="hesr14200-kwd-0004">opioid overdose</kwd><kwd id="hesr14200-kwd-0005">pharmacy</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>National Institute on Drug Abuse
</institution><institution-id institution-id-type="doi">10.13039/100000026</institution-id></institution-wrap></funding-source><award-id>R01DA045745</award-id><award-id>P30DA040500</award-id><award-id>U01DA047408</award-id></award-group></funding-group><funding-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>National Center for Injury Prevention and Control
</institution><institution-id institution-id-type="doi">10.13039/100005217</institution-id></institution-wrap></funding-source><award-id>R01CE002999</award-id></award-group></funding-group><funding-group><award-group id="funding-0003"><funding-source>National Institute on General Medical Sciences</funding-source><award-id>P20GM125507</award-id></award-group></funding-group><counts><fig-count count="3"/><table-count count="2"/><page-count count="10"/><word-count count="6149"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>October 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.3.3 mode:remove_FC converted:05.09.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="hesr14200-cit-9001"><string-name name-style="western"><surname>Chatterjee</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Yan</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Lambert</surname><given-names>A</given-names></string-name>, et al. <article-title>Comparison of a national commercial pharmacy naloxone data source to state and city pharmacy naloxone data sources&#8212;Rhode Island, Massachusetts, and New York City, 2013&#8211;2019</article-title>. <source>Health Serv Res</source>. <year>2023</year>;<volume>58</volume>(<issue>5</issue>):<fpage>1141</fpage>&#8208;<lpage>1150</lpage>. doi:<pub-id pub-id-type="doi">10.1111/1475-6773.14200</pub-id><pub-id pub-id-type="pmid">37408299</pub-id><pub-id pub-id-type="pmcid">PMC10480090</pub-id></mixed-citation>
</p></notes></front></article></pmc-articleset>